Figure 1

Resistance genotypes in patients failing RAL-based salvage therapy in the BENCHMRK study (from Cooper et al., N Engl J Med 2008). The bars indicate the proportion of viruses carrying the indicated mutations within the population of patients exhibiting virological failure of raltegravir-based therapy.